Treatment of sleep disorders using CNS target modulators

Details Treatment of sleep disorders using CNS target modulators Treatment of sleep disorders using CNS target modulators

2007-03-13

2007-03-13

Kwon, Brian (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S450000, C514S320000, C514S324000, C514S325000

Reexamination Certificate

active

10272510

ABSTRACT:
The invention is directed to compositions used for treating Central Nervous System (CNS) disorders. In addition, the invention provides convenient methods of treatment of a CNS disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for a discrete period of time to reduce side effects. More specifically, the invention is directed to the compositions and use of derivatized, e.g., ester or carboxylic acid derivatized, antihistamine antagonists for the treatment of sleep disorders.

REFERENCES:
patent: 3928356 (1975-12-01), Umio et al.
patent: 4072756 (1978-02-01), Ebnother et al.
patent: 4383999 (1983-05-01), Bondinell et al.
patent: 4514414 (1985-04-01), Bondinell et al.
patent: 4610995 (1986-09-01), Coker et al.
patent: 4929618 (1990-05-01), Koda et al.
patent: 4931450 (1990-06-01), Sonnewald
patent: 5095022 (1992-03-01), Ito et al.
patent: 5153207 (1992-10-01), Ito et al.
patent: 5225559 (1993-07-01), Kita et al.
patent: 5231105 (1993-07-01), Shoji et al.
patent: 5502047 (1996-03-01), Kavey
patent: 5643897 (1997-07-01), Kavey
patent: 5714501 (1998-02-01), Timmerman et al.
patent: 5776969 (1998-07-01), James
patent: 5801175 (1998-09-01), Afonso et al.
patent: 6054458 (2000-04-01), Jørgensen et al.
patent: 6174880 (2001-01-01), Bernstein
patent: 6174898 (2001-01-01), Weis et al.
patent: 6191165 (2001-02-01), Ognyanov et al.
patent: 6214827 (2001-04-01), Afonson et al.
patent: 6288083 (2001-09-01), Luly et al.
patent: 6288084 (2001-09-01), Luly et al.
patent: 6307052 (2001-10-01), Kita et al.
patent: 6358944 (2002-03-01), Lederman et al.
patent: 6387930 (2002-05-01), Baroudy et al.
patent: 6391890 (2002-05-01), J.o slashed.rgensen et al.
patent: 6503926 (2003-01-01), Luly et al.
patent: 0 335 586 (1989-10-01), None
patent: 0 399 414 (1990-11-01), None
patent: 451772 (1991-10-01), None
patent: 0 949 260 (1999-10-01), None
patent: 03133956 (1991-06-01), None
patent: 05-17442 (1993-01-01), None
patent: 05-17443 (1993-01-01), None
patent: 05-294929 (1993-11-01), None
patent: 2001-261553 (2001-09-01), None
patent: 2004-051600 (2004-02-01), None
patent: WO 88/09656 (1988-12-01), None
patent: WO 95/01350 (1995-01-01), None
patent: WO 96/31478 (1996-10-01), None
patent: WO 97/45115 (1997-12-01), None
patent: WO 00/14064 (2000-03-01), None
patent: WO 03/033489 (2003-04-01), None
Andersen et al.J. Med. Chem., 36(12):1716-1725 (1993).
Andersen et al.J. Med. Chem., 42:4281-4291 (1999).
Dhar et al.Bioorg. Med. Chem. Lett., 6(13):1535-1540 (1996).
Falch et al.Eur. J. Med. Chem., 26:69-78 (1991).
Iwasaki et al.Chem. Pharm. Bull., 42(11):2276-2284 (1994).
Iwasaki et al.Chem. Pharm. Bull., 42(11):2285-2290 (1994).
Muramatsu et al.Chem. Pharm. Bull., 41(11)1987-1993 (1993).
N'Goka et al.J. Med. Chem., 34(8):2547-2557 (1991).
Ohshima et al.J. Med. Chem., 35(11):2074-2084 (1992).
Patani et al.Chem. Rev., 96(8):3147-3176 (1996).
Yunger et al.J. Pharmacol. Exp. Ther., 228(1):109-115 (1984).

Affiliated with

Also associated with

Rating

Treatment of sleep disorders using CNS target modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of sleep disorders using CNS target modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of sleep disorders using CNS target modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3802178